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Objectives: To investigate the effect of partially defatted Granulated Brazil nut (GBN) on biomarkers of oxidative
stress and antioxidant status of hypertensive and dyslipidemic patients on nutrition and drug approaches.
Methods: Ninety one hypertensive and dyslipidemic subjects of both genders (51.6 % men), mean age 62.1 ± 9.3 years,
performed a randomized crossover trial, double-blind, placebo controlled. Subjects received a diet and partially defatted
GBN 13 g per day (≈227.5 μg/day of selenium) or placebo for twelve weeks with four-week washout interval.
Anthropometric, laboratory and clinic characteristics were investigated at baseline. Plasma selenium (Se), plasma
glutathione peroxidase (GPx3) activity, total antioxidant capacity (TAC), 8-epi PGF2α and oxidized LDL were evaluated at
the beginning and in the end of each intervention.
Results: GBN intake significantly increased plasma Se from 87.0 ± 16.8 to 180.6 ± 67.1 μg/L, increased GPx3 activity in
24,8 % (from 112.66 ± 40.09 to 128.32 ± 38.31 nmol/min/mL, p < 0,05), and reduced 3.25 % of oxidized-LDL levels (from
66.31 ± 23.59 to 60.68 ± 20.88 U/L, p < 0.05). An inverse association between GPx3 and oxidized LDL levels was observed
after supplementation with GBN by simple model (β -0.232, p = 0.032) and after adjustment for gender, age, diabetes and
BMI (β -0.298, p = 0.008). There wasn’t association between GPx3 and 8-epi PGF2α (β -0.209, p = 0.052) by simple model.
Conclusion: The partially defatted GBN intake has a potential benefit to increase plasma selenium, increase enzymatic
antioxidant activity of GPx3 and to reduction oxidation in LDL in hypertensive and dyslipidemic patients.
Trial registration: ClinicalTrials.gov Identifier NCT01990391; November 20, 2013.
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Brazil nut is the food retaining the largest amount of sel-
enium (Se) in its composition [1]. Se is a key component
incorporated to selenoproteins involved in enzymatic
functions of antioxidant, anti-inflammatory and thyroid
hormones metabolism [2, 3]. It was demonstrated that
the Brazil nut intake is able to significantly improve
glutathione peroxidase (GPx) activity on individuals with
low plasma Se [4]. GPx is a selenoprotein involved in
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creativecommons.org/publicdomain/zero/1.0/Reactive oxygen species (ROS) production is part of
the human metabolism and is found in many physiological
conditions [5]. Although, when there is an overproduction
of ROS the body has an efficient antioxidant system avail-
able, which manages to control and reestablish balance.
Therefore, the oxidative stress results from the imbalance
of pro and antioxidants, with predominance of oxidants
and consequent oxidative damage [6]. There is an association
between atherosclerosis risk factors and ROS vascular pro-
duction increase, since the main risk factors are genetics,
age, hypertension, dyslipidemia, diabetes and tobacco use [7].
Lipoxygenases are production sources of ROS, since
they catalyze the oxygen incorporation in polyunsaturated
fatty acids [8]. Some lipoxygenase isoforms are related to
the promotion of atherosclerosis by ROS generation ands article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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dividuals, the amount of circulating oxidized-LDL, in-
dependently, is a predictor to atherosclerosis [10] and
clinical coronary artery disease [11]; based in these situ-
ations, oxidized-LDL plasma concentration evaluation has
been suggested as a risk biomarker for CVD, besides LDL-c
concentrations. F2-isoprostanes are oxidized products of
arachidonic acid generated from non-enzymatic reactions;
they can derive from esterified fatty acids such as phospho-
lipid membrane or circulating LDL [12]. Once formed,
these compounds are structurally stable in vivo, circulating
in its free form or remaining esterified in phospholipids;
there can be found in both urine and plasma, hence consid-
ered good oxidative stress biomarkers [13].
Hypertension is one of the risk factors for acute myocar-
dial infarction (MI), heart failure, stroke, peripheral arterial
disease, aortic aneurysm and is one of the causes of chronic
kidney disease [14]. Hypertension is associated to increase
in oxidative stress and reduction of two antioxidant enzymes
activity [15]. High levels of serum LDL-c and triglycerides,
and low levels of HDL-c are also risk factors for cardiovas-
cular disease [16] and a study presents that different types
of hyperlipidemia are associated to oxidative stress [17].
Our hypothesis is based on the benefit effect related
to the bioactive compounds of the Brazil nut on
the management of hypertension and dyslipidemia, in
order to improve antioxidant status in such individuals.
The aim of this study was to investigate the effect of
partially defatted Granulated Brazil nut on biomarkers
of oxidative stress and antioxidant status of hyperten-




One hundred and thirty-seven subjects were screened at
the Clinic of Atherosclerosis and Cardiovascular Disease
Prevention of the National Institute of Cardiology, Rio
de Janeiro, RJ, Brazil, from September 2011 to September
2012. All the patients have been followed by a multidiscip-
linary team at the moment of the recruitment for the
present study. Of the 137 subjects screened, 125 patients
were eligible for the study. Males and females aged > 20 years
with a referred diagnosis of dyslipidemia and hypertension
that were taking medication for both conditions were in-
cluded in the study. The exclusion criteria was food allergy
to the Brazil nut; pregnancy or breastfeeding; undergoing in
a low calorie diet; using dietary supplements containing
antioxidant vitamins or minerals; using corticoid substances;
and thyroid diseases, chronic renal failure, liver disease, can-
cer, rheumatic disease or systemic connective tissue disease.
The Ethics Committee in Research of the National Institute
of Cardiology, protocol 0316/11, approved the study, and it
was registered at ClinicalTrials.gov (NCT01990391).Study design and dietary intervention
A randomized, placebo-controlled, double-blind cross-
over trial was performed. Subjects were provided either
partially defatted Granulated Brazil nut or placebo
along with nutritional counselling for dyslipidemia and
hypertension [18, 19]. Each supplementation period
lasted three months (twelve weeks) with monthly
returns. After the first step of intervention, subjects
underwent a washout period of four-week, based on
SELGEN study [20], when did not receive any supple-
ments. Randomization was simple, in blocks of 10 and
based on a table of random numbers that were blinded
from all researchers except one who encoded the bot-
tles of supplements and had no contact with the center
where the study was conducted.
Subjects were advised to use 01 standard measure con-
taining 13 g per day (on average containing 227.5 μg of
selenium) of partially defatted Granulated Brazil nut
(Ouro Verde Amazônia® - Mato Grosso, Brazil). Partially
defatted granulated Brazil nut was used in this study in-
stead of Brazil nut kernel because the Granulated Brazil
nut has high Se content compared to the Brazil nut
(227,5 μg vs. 249,21 μg [21], respectively) and similar
centesimal composition between each other, except for
the total fat decrease and less calorie. In addition,
Granulated Brazil nut allowed to blind the study and
is already commercialized. The placebo (Mane do
Brazil Indústria e Comércio Ltda, Rio de Janeiro,
Brazil) was composed of flavored cassava flour (which
has a nutty aroma) and was lightly stained (with nat-
ural caramel pigment) to approximate the appearance
and smell of Granulated Brazil nut. Subjects were
advised to consume 01 standard measure containing
10 g daily of placebo. The calculation of the diet was indi-
vidualized and based on Total Energy Expenditure (TEE)
formulas for men and women according to their nutri-
tional status, age, and used the physical activity coefficient
of 1.0 which is related to physical inactivity [22]. The dis-
tribution of macronutrients was balanced, and nutritional
counselling followed the guidelines for hypertension and
dyslipidemia [18, 19].Composition of the supplements
Partially defatted Granulated Brazil nut (Ouro Verde
Amazônia® - Mato Grosso, Brazil) is made by the mechan-
ical cold extraction of the extra-virgin oil of Brazil nut at
atmosphere temperature. Thirteen grams of the partially
defatted Granulated Brazil nut contained 64.4 kcal, 2.8 g
carbohydrate, 3.4 g protein, 5.6 g total fat and 2.6 g dietary
fiber. Ten grams of the placebo (flavored cassava flour)
had a nutritional composition of [21]: 36.5 kcal, 8.92 g
carbohydrate, 0.12 g protein, 0.03 g total fat, 0.65 g dietary
fiber and 0.07 μg selenium.
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The selenium content was analyzed according to the
method described by Benicasa et al. [23] and adapted to
use 0.3 g of sample, 6 mL of bidistilled nitric acid and
3 mL of hydrogen peroxide (both from Merck®, Germany).
Samples were decomposed in a microwave oven (Provecto
Analitica DGT 100 plus). The resulting solutions were
transferred to polyethylene flasks and diluted to 50 mL
with distilled and deionized water (MilliQ System,
Millipore, USA, minimum resistivity of 18 MΩ cm).
The reading of the 77Se isotope was performed by ICP-
MS (Agilent 7500 CX series). The accuracy was evaluated
by recovery tests and analysis of a dogfish liver certified
reference material for trace metals (DOLT-3, National Re-
search Council Canada standard, Canada). Recoveries of
approximately 100 % were observed. The amount of Se
observed in Granulated Brazil nut was 17.5 ± 0.2 μg/g,
corresponding to 227.5 μg in 13 g of BNG.
Evaluation questionnaires
A questionnaire was used to obtain information about
sociodemographics characteristics, medical history, life-
style, and the use of current medication. To assess phys-
ical activity, a previously validated questionnaire was used
[24]. Patients who performed at least 150 min of moderateFig. 1 Flow chart of patients in each study phaseintensity exercise per week, according to international rec-
ommendations, were considered physically active [25].
Anthropometric, blood pressure and laboratory
measurements
Anthropometric evaluation was performed at baseline
and included measurements of weight (kg), height (m),
waist circumference (cm) and calculation of BMI (kg/m2).
BMI was classified according to WHO [26].
Systolic blood pressure (SBP) and diastolic blood pres-
sure (DBP) were evaluated using a sphygmomanometer.
The SBP and DBP were measured twice by a trained
professional, with a 1 min interval between the two
measurements and the average value was used as the
patient’s blood pressure.
Blood samples were collected after 12 h of overnight fast-
ing, and laboratory evaluations were performed by an auto-
mated method (ARCHITECT ci8200, Abbott ARCHIECT®,
Abbott Park, IL, USA) using commercial kits (Abbott
ARCHITECT c8000®, Abbott Park, IL, USA). Serum trigly-
ceride levels, total cholesterol and HDL-cholesterol
(HDL-c) were evaluated. The LDL-cholesterol (LDL-c)
were calculated using the Friedewald et al. formula [27].
Plasma Se levels were determined in plasma samples
collected in NH Trace Element tubes with sodium
heparin (VACUETTE®) and stored at − 20 °C until the
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ductively coupled plasma mass spectrometer (NexIon™
300X, PerkinElmer, Massachusetts, USA), following
the method adapted from [28]. Plasma samples (0.5 g)
were added with 0.5 mL nitric acid and diluted with
water to 5.0 mL final volume. In this case, most abun-
dant 80Se isotope was monitored, due to the low Se
concentrations found in plasma samples and the ana-
lysis was carried out in DRC mode with 0.75 mL min−1
of methane to circumvent the interferences. The plasma
Se levels were used as a marker of adherence to the
consumption of the supplement. Plasma Se was consid-
ered to be low when plasma levels were <90 μg/L [29].Table 1 Characteristics of the group that completed the study com
Completed
(n = 91)
Age (years) 62.1 ± 9.3
Male – n (%) 47 (51.6)
Diabetics – n (%) 42 (46.2)
Stroke – n (%) 06 (6.6)
AMI – n (%) 39 (42.9)
Percutaneous coronary 22 (24.2)
Angioplasty – n (%)
CABG – n (%) 29 (31.9)
Angina – n (%) 36 (39.6)
Time of diabetes (years) 10.6 ± 11.2
Time of hypertension (years) 11.8 ± 9.7
Time of dyslipidemia (years) 10.1 ± 9.7
Smokers – n (%) 02 (2.2)
Alcohol use – n (%) 32 (37.2)
Sedentary – n (%) 68 (74.7)
Marital status (married) – n (%) 54 (60.0)
Schooling – n (%)
0 – 9 years 64 (71.1)
10 – 12 years 18 (20.0)
≥12 years 08 (8.9)
BMI (kg/m2) 28.8 ± 5.1
WC (cm) 100.1 ± 12.3
SBP (mmHg) 146.5 ± 28.7
DBP (mmHg) 81.8 ± 13.7
Glucose (mg/dL) 109.0 (90.0 - 137.0)
Triglycerides (mg/dL) 153.0 (119.0 - 226.0)
Total cholesterol (mg/dL) 204.4 ± 61.7
HDL-cholesterol (mg/dL) 39.7 ± 12.3
LDL-cholesterol (mg/dL) 125.8 ± 54.8
n (%), Mean ± SD, Median (25th–75th percentile). Chi-square test, Student’s t-test, § M
coronary artery bypass grafting, BMI: body mass index, WC: waist circumference,
lipoprotein, LDL: low density lipoproteinThe antioxidant activity of plasma glutathione per-
oxidase (GPx3) was determined by colorimetric assay
(Cayman Inc., US) based on Paglia& Valentine method
[30] with sensibility of 50 nmol/min/mL, intra-assay
variation coefficient 5.7 % and inter-assay variation co-
efficient 7.2 %.
Plasma total antioxidant capacity (TAC) was evaluated
by radical 2,2-diphenyl-1-picrylhydrazyl scan (DPPH)
[31].
As oxidative stress markers 8-isoprostane (8-epi PGF2α)
and oxidized LDL were assessed in plasma. Concentra-
tions of 8-epiPGF2a in the plasma samples were deter-
mined by ELISA method [32, 33] with commercial kitpared to those who did not complete the study
Did not complete p
(n = 34)








4.9 ± 7.9 NS
10.7 ± 8.6 NS








30.8 ± 5.5 NS
104.4 ± 12.5 NS
137.9 ± 21.1 NS
83.2 ± 13.0 NS
120.0 (102.5 - 174.0) 0.030§
211.0 (118.0 - 456.5) NS §
217.7 ± 114.7 NS
35.8 ± 9.2 NS
116.8 ± 61.9 NS
ann–Whitney test. NS: non-significant, AMI: acute myocardial infarction, CABG:
SBP: systolic blood pressure, DBP: diastolic blood pressure, HDL: high density
Fig. 2 Plasma Se levels during intervention with Brazil nut, placebo and washout period. Data are expressed as the mean ± SD. Student’s t-test
between placebo and Granulated Brazil nut groups. * p < 0.05
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sensibility of 2.7 pg/mL.
Oxidized LDL was determined by ELISA method [34, 35]
with commercial kit (Mercodia, Uppsala, Sweden). Samples
were diluted in 1:6400. The intra-assay variation coefficient
was 6.13 % and the sensibility was 0.05 ng/mL.
Statistical methods
The sample size calculation was performed with a pilot
sample made up of the first 10 participants, considering
an increase of 15 nmol/min/mL (15 %) on GPx3 activity
after Brazil nut intervention. A power of 80 % and a
bilateral confidence interval of 90 % were considered.
The calculated sample size was 63 per group and this
number was increased by 30 % (to total 81 subjects) to
account for possible losses. The results were presented
as the mean ± SD or median (25th–75th percentile).
The normality of the variables was investigated using
the Kolmogorov-Smirnov test. To assess the intra inter-
vention group’s (Granulated Brazil nut and placebo) effect
the paired Student’s t-test was used, while the effect
between groups was assessed by the Student’s t-test or
Mann–Whitney test according to the distribution of vari-




GPx3 (nmol/min/mL) 107.53 ± 27.79 115.06 ±
TAC (%) 20.36 ± 4.44 18.75 ± 5
8-epi PGF2α (pg/mL) 14.57 ± 7.84
d 16.37 ± 9
Oxidized LDL (U/L) 64.43 ± 20.97 63.76 ± 2
Ox LDL /LDL-c 0.56 ± 0.18 0.57 ± 0.1
Mean ± SD. a, b, c, d, e p < 0.05. Means followed by the same alphabetic letter are sta
plasma glutathione peroxidase; TAC: total antioxidant capacity of plasma; 8-epi PGF
density lipoproteinsignificant. Simple and multiple linear regression models
were used to analyze relationships between GPx3 activity
and oxidized LDL and 8-epi PGF2α. Multiple linear re-
gression model was adjusted for gender, age, diabetes and
BMI. Statistical analyses were conducted with IBM® SPSS®
Statistics software version 21 and the significance value
considered was p < 0.05.
Results
One hundred and twenty five patients were randomized
and 91 concluded all stages of the study, resulting in a
27.2 % loss of follow up. Figure 1 shows the flow chart
and losses throughout the study. The drop out in the
follow-up was higher during supplementation with partially
defatted Granulated Brazil nut, but there was no report of
withdrawal due to the taste of the supplement. Individuals
who completed the study protocol were older, with less
schooling and lower serum glucose (Table 1), in relation to
other parameters, there was no difference between patients
who did not complete and those who completed the study.
A larger part of the study group was elderly (57.1 %)
and there was no difference in gender distribution. Main
comorbidities were diabetes and overweight and obesity,
and the main events among clinical procedures wereioxidant status and oxidative stress markers in hypertensive and
Diet + Granulated Brazil nut
Before 12 weeks
38.09 a 112.66 ± 40.09 b 128.32 ± 38.31 b, a
.64 c 20.13 ± 4.68 20.41 ± 4.80 c
.81d 15.83 ± 9.50 15.65 ± 8.08
3.03 66.31 ± 23.59 e 60.68 ± 20.88 e
9 0.57 ± 0.18 0.53 ± 0.15
tistic different. Paired Student’s t-test (b, d, e) and Student’s t-test (a, c). GPx3:
2α: 8-epi prostaglandine F2α; LDL: low density lipoprotein; Ox LDL: oxidized low
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(Table 1). The drugs mostly used by the group were: statins
(81.3 %), fibrates (33 %), oral hypoglycemic agents (48.4 %),
sympatholytic agents (72.5 %), ACE inhibitors (53.8 %), di-
uretics (49.5 %), calcium channel blockers (40.7 %), AT1 re-
ceptor blockers (36.3 %), vasodilators (12.1 %), ASA (65.9 %).
Although all patients received treatment for dyslipid-
emia and hypertension, 60.4 % presented increased ar-
terial blood pressure (systolic ≥ 140 mmHg or diastolic ≥
80 mmHg). In relation to serum lipid concentrations
94.5 % of the patients presented some alteration on their
lipid profile at the beginning of the study, being 52.7 %
increased triglycerides (≥150 mg/dL), 60.4 % increased
LDL-c (>100 mg/dL) and 33.3 % presented both param-
eters altered.
There was no change on the evolution of anthropomet-
ric and clinical parameters after twelve weeks of placebo
and Brazil nut dietary interventions (data not shown), as
no difference was present between diets, at the beginning
or the ending periods. The same occurred for most of
the biochemical parameters, however, a significant in-
crease of HDL-c can be observed in both intervention
groups (Diet + Placebo: 38.96 ± 13.30 to 41.17 ± 12.82;
p < 0.05 and Diet + Granulated Brazil nut: 38.66 ± 11.91
to 40.82 ± 14.73; p < 0.05).
Basal plasma Se concentration from the study group
was 87.0 ± 16.8 μg/L and it was observed that 57.1 %
(n = 52) presented low plasma Se (<90 μg/L). ThroughoutFig. 3 Changes at 12 weeks in the markers of antioxidant status and oxida
glutathione peroxidase; TAC: total antioxidant capacity of plasma; 8-epi PGFintervention, Se plasma concentrations increased signifi-
cantly with the *Brazil nut intake (Fig. 2). It has been ob-
served an overall increase in Plasma Se by 119 %. However,
it was possible to verify the carry over effect after the wash-
out period on placebo diet Se concentrations; this occurred
because part 112of the study group who received Granu-
lated Brazil nut supplementation on the first steps did
not return to the same basal values, making plasma Se
initial value to be elevated in relation to Granulated
Brazil nut supplementation initial value.
Significant increase of GPx3 activity and oxidized-LDL
reduction with Granulated Brazil nut intake was observed
(Table 2). At the end of 12 weeks plasma total antioxidant
capacity was lower on the placebo diet than on the Brazil
nut diet (p = 0.024).
The oxidative stress markers variation percentage and
antioxidant capacity according to dietary intervention at
the end of the study is presented in Fig. 3. It was ob-
served increase in GPx3 activity by 24.8 % in Granulated
Brazil Nut and it was statistical different from placebo
(p = 0.034), an oxidized-LDL reduction by 3.2 % after
Granulated Brazil Nut intervention but it was no stat-
istical different from placebo. There were no statis-
tical difference between Granulated Brazil Nut and
placebo for plasma total antioxidant capacity and 8-epi
PGF2α (Fig. 3).
A significant inverse association between oxidized-LDL
and GPx3 activity after Granulated Brazil nut intake istive stress. # p < 0.05. Student’s t-test (a, b, c, d). GPx3: plasma
2α: 8-epi prostaglandin F2α; LDL: low density lipoprotein
y Placebo = -0,0592x + 70,493 
R² = 0,0095


























Linear (Granulated Brazil nut)
A
B
y Placebo = -0,0059x + 17,137 
R² = 0,0005
























Linear (Granulated Brazil nut)
Fig. 4 Association between GPx3 activity and biomarkers of oxidative stress. Simple linear regression. a. Granulated Brazil nut (p = 0.032) and
Placebo (p = 0.371); b. Granulated Brazil nut (p = 0.052) e Placebo (p = 0.836)
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(B − 0.434, IC 95 % − 0.829;−0039, β − 0.232, p = 0.032)
and it remained significant after adjustment for age,
BMI, gender, diabetes and smoking status (B − 0.556, IC
95 % − 0.963;−0148, β − 0.298, p = 0.008). However no
statistical significance was observed between 8-epi
PGF2α and GPx3 activity with the simple linear re-
gression model (B − 0.991, IC 95 % − 1.991;−0009, β −
0.209, p = 0.052) as shown in Fig. 4. Nevertheless, a
significant inverse association between 8-epi PGF2α
and GPx3 activity was achieved after adjustment for
age, BMI, gender and diabetes (B − 1.082, IC 95 % −
2.081;−0.084, β − 0.234, p = 0.034).
Discussion
The present study showed that the partially defatted
Granulated Brazil nut (13 g/day, providing 227.5 μg) in a
serum lipid and blood pressure reduction diet for dyslip-
demic and hypertensive patients, increased antioxidant
status and reduced oxidative stress. The relationship of
these effects were inversely proportional.The Brazil nut also has an important amount of antioxi-
dants compounds, such as almonds, hazelnuts, macada-
mia nuts, pine cones, and cashew nuts [36]. The Brazil
nut is the food with the highest amount of Se in its com-
position [1]. Se is a mineral which is involved with the
protection against oxidative stress via selenoproteins as
glutathione peroxidase, participanting of this enzyme ac-
tive site [29]. Besides, Brazil nut is high in β-tocopherol
(88.3 % of total tocopherols), a potent antioxidant [37].
Thomson et al. demonstrated that the Brazil nut in-
take significantly improved GPx activity on individuals
with low plasma Se compared to selenomethionine or
placebo [4]. SELGEN study measured the Se status of
healthy volunteers before and after supplementation
with 100 μg Se/day for six weeks followed by a washout
period of six weeks, and the authors showed a rapid and
significant decrease in plasma Se status to baseline
levels after two weeks and continued to fall at fourth
week after which time it was similar to baseline con-
centration [20]. However in the present study there
was a carryover effect, maybe because of the selenium
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main pools of Se in human body are selenoproteins
and selenomethionine [38].
Many enzymatic processes can generate ROS on the
human body, and there are evidences that connect these
processes to cardiovascular diseases pathophysiology
[12]. The lipid peroxidation process is initiated by a ROS
reaction with a unsaturated fatty acid and propagated by
peroxyl radicals [39]. Glutathione peroxidase biochem-
ical function is reducing lipid hydroperoxides to their
correspondent alcohols and decreasing free hydrogen
peroxide to water [40]. GPx1 enzyme (eritrocity) activity
was reduced in CAD patients and low activity of this en-
zyme was a predictor to cardiovascular event in five-year’s
time [41]. Similar to the present study, other studies also
observed GPx activity increase after Brazil nut supple-
mentation in obese women [42] and CKD patients in
hemodialysis [43]. In addition, it has been observed that
the overall increase in Plasma Se and plasma GPx activ-
ity was higher than Thomson et al. showed with a low
plasma Se subjects [4].
The oxidation of LDL was increased in the familial
hypercholestolemia, hypertriglyceridemia, diabetes and
coronary artery disease [44]. Clinical trials evaluating dif-
ferent types and quantities of nuts indicated improve-
ment of oxidative stress after nuts’ intake [45]. The
reduction of average 15 % on oxidized-LDL in hyperlip-
idemic men and women was observed after almonds in-
take (37 or 75 g/day) for a month, compared to the
control diet [46]. The present study showed a modest
significant reduction in oxidized-LDL after Granulated
Brazil nut intake, and it can be attributed to the complex
health status of these patients related to duration of dis-
ease, previous cardiovascular event and poor blood pres-
sure control and serum lipids control, which may have
influenced the findings. However, the observation of
such reduction has been inversely associated with
GPx3 activity increase, demonstrating a beneficial rela-
tionship of Brazil nut antioxidants properties as part
of hypertensive and dyslipidemic patients’ nutrition
intervention.
High concentrations of F2-isoprostanes are associated
with the coronary artery disease extension and severity
[47]. In other study, the Brazil nut intake (15 a 25 g/day)
for four months did not alter urinary 8-epi PGF2α in
female obese teenagers [48]. In the same way, 13 g/day
Granulated Brazil nut consumption in the present
study did not alter 8-epi PGF2α plasma concentration
after twelve week, but an inverse correlation of this
biomarker was observed with GPx3 activity, however
it was not significant.
The present study has limitations that may have influ-
enced the findings. Such limitations include the cohort
of participants who did not complete the study whoseage was significantly less than those who did complete
the study, the relative short intervention period, the het-
erogeneity of the participants, and the carry-over effect
in relation to plasma selenium concentrations. However,
the crossover design allows the patient to be their own
control. Finally, partially defatted Granulated Brazil nut
are easy to include in one’s diet and use in daily recipes.
The present study contributes to the rising evidence
which demonstrates the beneficial effects of nuts over
CVD risk factors. Our data showed that Granulated
Brazil nut can be recommended as part of a healthy diet
for the heart, since it has a potential benefit to increase
plasma selenium, increase enzymatic antioxidant activity
of GPx3 and to reduction oxidation in LDL in hyperten-
sive and dyslipidemic patients.
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